PROLIFIC: Prognostic Lung Fibrosis Consortium supports researchers developing and validating blood-protein biomarker assays to advance pulmonary fibrosis drug development and help tailor treatment.
PFF Registry Ancillary Studies supports clinical and translational investigators with Registry data, biosamples, and scans to study pulmonary fibrosis and interstitial lung disease and improve care.
PFF Scholars supports early-career investigators through mentored pulmonary fibrosis research and career development to improve disease understanding and build toward independent research funding.
Parkinson's Disease Biomarker Innovation and Advancement Program supports teams developing fluid- and imaging-based biomarkers for clinical implementation and broader use in Parkinson's research.
Investigator Initiated Research Programs support researchers and trainees pursuing basic and translational Lipedema research to advance diagnostics and build capacity for clinical trials and new therapeutics.
Litwin IBD Pioneers supports scientists pursuing early-stage clinical and translational research on Crohn's disease and ulcerative colitis to improve patient diagnosis, treatment, management, or prevention.